Journal profile · Oncology
Advances in Cancer Research
ISSN 0065-230X · eISSN 2162-5557 · Academic Press Inc. · UNITED STATES · Irregular
Advances in Cancer Research: impact factor 7.41; subscription journal; community-reported acceptance: fairly hard; 59 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Advances in Cancer Research is published by Academic Press Inc.. By OpenAlex counts of its recent articles, its largest topics are Immunotherapy and Immune Responses, Cancer-related Molecular Pathways and Viral-associated cancers and disorders, together about 25.2% of its articles. Its main subfields are Oncology and Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Read the latest chapters of Advances in Cancer Research at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
From the journal's Aims & Scope
Research area (LetPub): Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immunotherapy and Immune ResponsesImmunology and Microbiology8.9%
- Cancer-related Molecular PathwaysMedicine8.4%
- Viral-associated cancers and disordersMedicine7.9%
- Cancer Cells and MetastasisMedicine7.7%
- T-cell and B-cell ImmunologyImmunology and Microbiology6.3%
- Cancer Immunotherapy and BiomarkersMedicine6.3%
- Protein Kinase Regulation and GTPase SignalingBiochemistry, Genetics and Molecular Biology4.5%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Oncology | Q1 | 84/428 | — |
| Cancer Research | Q2 | 75/233 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.41LetPub ·
- CiteScore 2026-06
- 7LetPub ·
- CiteScore (publisher)
- 10Publisher website ·
- SJR 2026-06
- 1.73LetPub ·
- SNIP 2026-06
- 0.91LetPub ·
- h-index
- 85LetPub ·
- h-index
- 174OpenAlex ·
- i10-index
- 1,103OpenAlex ·
- 2-year mean citedness
- 1.96OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 37LetPub ·
Articles by year OpenAlex count · 2,143 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 56 | 1 | 2,030 |
| 2025 | 59 | 1 | 3,587 |
| 2024 | 51 | 6 | 4,247 |
| 2023 | 43 | 6 | 4,356 |
| 2022 | 64 | 19 | 4,265 |
| 2021 | 47 | 8 | 4,256 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average acceptance (community reports)
- Fairly hardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Academic Press Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Irregular
- ISSN
- 0065-230X
- Electronic ISSN
- 2162-5557
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Advances in Cancer Research
What is the impact factor of Advances in Cancer Research?
The latest impact factor listed by LetPub is 7.41; CiteScore 7, h-index 174.
Which databases index Advances in Cancer Research?
According to LetPub and DOAJ records, Advances in Cancer Research is indexed in Scopus.
Is Advances in Cancer Research open access, and what is the APC?
Advances in Cancer Research is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .